Vulnerable plaque identification and its importance to patients
Heart disease is the leading cause of death globally, responsible for an estimated 17.9 million1 lives lost each year and causing 1 death every 34 seconds in the US alone2.
Featured & Latest News
Learn More
Supporting Clinical Decision-Making with AI
As AI and deep learning evolve, software can sometimes match human specialists in its accuracy for sensing, imaging, triaging or risk profiling tasks. Find out more about AI accuracy.
I’d like to thank my wife and my children, for supporting me through this massive journey.
Today is a momentous occasion in the life of a business that we created two and a half years ago.
The future has landed
In two-and-a-half years, Artrya has developed a novel approach to the detection and reporting of coronary artery disease. We have grown into a $100m company with leading technology that can rewrite the medical history books.
Cardiac imaging now and into the future
Cardiac imaging is a specialised area of radiology practice to visualise the heart and its associated valves, vessels and other structures.
Why current CAD diagnostics might not see patient heart attack coming
The case for vulnerable plaque. Every 40 seconds across the United States, another person experiences a heart attack. According to the Centers for Disease Control and Prevention, myocardial infarctions (heart attacks)…
Advances in healthcare technology shaping the future of medicine
How digital transformation is changing disease diagnoses, monitoring and treatments.
Podcast: Artrya using big data to detect coronary artery disease
John Barrington AM, Managing Director and Co-Founder at Artrya chats with Peter Strachan on a special med instalment of the Rock Yarns podcast.